No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Insulin Efsitora is Noninferior to Degludec in Type 2 Diabetes without Previous Insulin Treatment

byAstrid BradshawandAlisha Yi

September 25, 2024

in StudyGraphics

Reading Time: 1 min read

Click here to read this study in NEJM.

©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Metformin remains a leading candidate for pharmacologic longevity intervention

Lilly’s retatrutide achieves significant weight loss and A1C reduction in Phase 3 trial

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

Adaptimmune’s Afami-cel is the first FDA-approved T-cell receptor therapy for synovial sarcoma

RelatedReports

Metformin treats Fragile X syndrome symptoms in mice [PreClinical]

Chronic Disease

Metformin remains a leading candidate for pharmacologic longevity intervention

May 19, 2026

Sleep duration inversely related to childhood type 2 diabetes risk makers

Cardiology

Lilly’s retatrutide achieves significant weight loss and A1C reduction in Phase 3 trial

April 3, 2026

2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]

Endocrinology

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

March 30, 2026

Risk of autism in offspring linked to maternal pregestational diabetes and severe obesity

Weekly Rewinds

2 Minute Medicine Rewind March 23, 2026

March 23, 2026

Drug-coated balloons are noninferior to drug-eluting stents for treatment of small vessel coronary artery disease

Ticagrelor monotherapy reduces bleeding risk compared to dual antiplatelet therapy for patients following coronary stenting

#VisualAbstract Telehealth vs In-Person Early Palliative Care for Patients with Advanced Lung Cancer

#VisualAbstract: Perioperative Durvalumab with Neoadju-vant Chemotherapy Improved Survival in Operable Bladder Cancer

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result